Evogene Reports Fourth Quarter and Full Year 2021 Financial Results
- Thursday, March 10, 2022, 7:15
- PR Newswire
- Add a comment
REHOVOT, Israel, March 10, 2022 /PRNewswire/ — Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today its financial results for the fourth…
About the Author
admin has written 21793 stories on this site.